247 results on '"Chan, Albert Chi Yan"'
Search Results
2. Correlation of pathological examination with indocyanine green (ICG) intensity gradients: a prospective study in patients with liver tumor
3. Post-transplant inflammatory cytokine signature adds value for predicting tumor recurrence after liver transplantation for hepatocellular carcinoma
4. Dual-tracer PET/CT in the management of hepatocellular carcinoma
5. Sorted-Cell Sequencing on HCC Specimens Reveals EPS8L3 as a Key Player in CD24/CD13/EpCAM-Triple Positive, Stemness-Related HCC Cells
6. Impact of Three-Dimensional (3D) Visualization on Laparoscopic Hepatectomy for Hepatocellular Carcinoma
7. Sequential transarterial chemoembolisation and stereotactic body radiotherapy followed by immunotherapy as conversion therapy for patients with locally advanced, unresectable hepatocellular carcinoma (START-FIT): a single-arm, phase 2 trial
8. PFKFB4 Drives the Oncogenicity in TP53-Mutated Hepatocellular Carcinoma in a Phosphatase-Dependent Manner
9. Magnetic resonance elastography and proton density fat fraction predict adverse outcomes in hepatocellular carcinoma
10. Impact of Time to Recurrence on Survival Outcome of Salvage Liver Transplantation
11. Complete Response to Locoregional Therapy Plus Immunotherapy for Hepatocellular Carcinoma.
12. RSK2-inactivating mutations potentiate MAPK signaling and support cholesterol metabolism in hepatocellular carcinoma
13. An international multicenter study of protocols for liver transplantation during a pandemic: A case for quadripartite equipoise
14. Single-cell RNA sequencing shows the immunosuppressive landscape and tumor heterogeneity of HBV-associated hepatocellular carcinoma
15. Life long follow up and management strategies of patients living with native livers after Kasai portoenterostomy
16. Liver transplantation using hepatitis B core positive grafts with antiviral monotherapy prophylaxis
17. Major postoperative complications compromise oncological outcomes of patients with intrahepatic cholangiocarcinoma after curative resection – A 13-year cohort in a tertiary center
18. Survival Outcome Analysis of Stereotactic Body Radiotherapy and Immunotherapy (SBRT-IO) versus SBRT-Alone in Unresectable Hepatocellular Carcinoma.
19. Peer-to-peer clinical teaching by medical students in the formal curriculum
20. Survival Outcome Analysis of Stereotactic Body Radiotherapy and Immunotherapy (SBRT-IO) versus SBRT-alone in Unresectable Hepatocellular Carcinoma (HCC)
21. Validated nomogram for the prediction of disease-free survival after hepatectomy for hepatocellular carcinoma within the Milan criteria: individualizing a surveillance strategy
22. Solitary extraovarian primary peritoneal carcinoma with direct invasion into the liver, diaphragm and lung without peritoneal dissemination or distant metastasis
23. Risk prediction model for major complication after hepatectomy for malignant tumour - A validated scoring system from a university center
24. Impact of Hepatitis B Carrier Status on the Outcomes of Surgical Treatment of Colorectal Liver Metastases
25. Hepatocholangiocarcinoma/intrahepatic cholangiocarcinoma: are they contraindication or indication for liver transplantation? A propensity score-matched analysis
26. Adjuvant chemotherapy improves oncological outcomes of resectable intrahepatic cholangiocarcinoma: A meta-analysis
27. Association of Multi-Phasic MR-Based Radiomic and Dosimetric Features with Treatment Response in Unresectable Hepatocellular Carcinoma Patients following Novel Sequential TACE-SBRT-Immunotherapy
28. Diagnostic and Prognostic Role of 18-FDG PET/CT in the Management of Resectable Biliary Tract Cancer
29. Efficacy of endoscopic self-expandable metal stent placement versus surgical bypass for inoperable pancreatic cancer-related malignant biliary obstruction: a propensity score-matched analysis
30. Impact of tumor biology on outcomes of radical therapy for hepatocellular carcinoma oligo-recurrence after liver transplantation
31. Verifying the benefits of radical treatment in posttransplant hepatocellular carcinoma oligo-recurrence: a propensity score analysis
32. Validated Nomogram for Prediction of Recurrence in HCC within Milan Criteria
33. Sex‐specific analysis of microRNA profiles in HBV‐associated cirrhosis by small RNA‐sequencing
34. IDDF2022-ABS-0176 Tumor-derived iron loaded-exosomes impair CD8+ T anti-tumor ability via ferroptosis in hepatocellular carcinoma
35. Impact of Tumour Biology on Outcomes of Radical Therapy for Hepatocellular Carcinoma Oligo-Recurrence after Liver Transplantation
36. Criteria for liver transplantation in ACLF and outcome
37. Stanniocalcin 1 is a serum biomarker and potential therapeutic target for HBV ‐associated liver fibrosis
38. Erratum: Defining the role of laparoscopic liver resection in elderly HCC patients: a propensity score matched analysis
39. Combined Stereotactic Body Radiotherapy and Immunotherapy Versus Transarterial Chemoembolization in Locally Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
40. Verifying the Benefits of Radical Treatment in Posttransplant Hepatocellular Carcinoma Oligo‐recurrence: A Propensity Score Analysis
41. Impact of Time to Recurrence on Survival Outcome of Salvage Liver Transplantation
42. The ‘Unsigned highway’: An alternative route for portal vein anastomosis for non-malignant portal vein thrombosis during pediatric re-transplantation
43. Durability of Small-for-Size Living Donor Allografts
44. Defining an optimal surgical strategy for synchronous colorectal liver metastases: staged versus simultaneous resection?
45. Prospective Study of Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma on Waitlist for Liver Transplant
46. Impact of three-dimensional (3D) visualization on laparoscopic hepatectomy for hepatocellular carcinoma
47. Liver transplantation: would it be the best and last chance of cure for hepatocellular carcinoma with major venous invasion?
48. Simultaneous portohepatic vein embolization a radiological: a short cut to associating liver partition and portal vein ligation for staged hepatectomy?
49. Analysis of Survival Benefits of Living Versus Deceased Donor Liver Transplant in High Model for End‐Stage Liver Disease and Hepatorenal Syndrome
50. Prognostic value and reversibility of liver stiffness in patients undergoing tricuspid annuloplasty
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.